商务合作
动脉网APP
可切换为仅中文
Apart from skin cancers, breast cancer is the most common cancer in women in the US. Image credit: Shutterstock/Buravleva stock.
除了皮肤癌之外,乳腺癌是美国女性中最常见的癌症。图片来源:Shutterstock/Buravleva stock。
GE HealthCare’s newest offering from its automated ultrasound system line represents a significant advancement in breast cancer screening, according to market analysis.
据市场分析,GE HealthCare最新的自动超声系统产品线代表了乳腺癌筛查的重大进展。
Invenia Automated Breast Ultrasound (ABUS) Premium, the latest ultrasound product that GE HealthCare
Invenia 自动乳腺超声(ABUS)Premium,是GE医疗最新的超声产品
rolled out this week
本周推出
, is designed to improve scanning in dense breasts.
旨在提高致密型乳腺的扫描效果。
Go deeper with GlobalData
深入了解更多GlobalData信息
Reports
报告
Robotics in Medical Devices: Surgical Robots
医疗器械中的机器人技术:手术机器人
Reports
报告
Australia Ultrasound Systems Market Outlook to 2025
澳大利亚超声系统市场展望至2025年
Data Insights
数据洞察
The gold standard of business intelligence.
商业智能的黄金标准。
Find out more
了解更多信息
Apart from skin cancers, breast cancer is the most common cancer in women in the US. It accounts for about 1 in 3 of all new female cancers each year. Over 70% of cancers occur in dense breasts, which are found predominantly in Asian women. GE HealthCare states that about one third of cancers in dense breasts go undetected due to shortcomings in standard mammography technology.
在美国,乳腺癌是女性除皮肤癌外最常见的癌症,约占每年所有新发女性癌症的三分之一。超过70%的癌症发生在致密型乳腺中,这种情况在亚洲女性中尤为普遍。GE医疗指出,由于标准乳腺X光技术的局限性,约三分之一的致密型乳腺中的癌症未能被检测出来。
Dense breast tissue refers to tissue that is more glandular and fibrous..
密集的乳腺组织是指更多的腺体和纤维组织。
Graysen Vigneux, Medical Analyst at GlobalData, comments: “For patients with dense breast tissue, where mammography alone may be insufficient, [GE HealthCare’s technology] provides a critical additional layer of detection, improving diagnostic accuracy and potentially saving lives.”
GlobalData的医疗分析师格雷森·维尼厄克斯评论道:“对于乳腺组织致密的患者来说,单独使用乳腺X光摄影可能不够充分,[GE医疗的技术]提供了关键的额外检测层面,提高了诊断准确性,并有可能挽救生命。”
The medtech giant has inserted artificial intelligence (AI) in ABUS to automate the imaging process and detection of cancers. The technology could also decrease unnecessary biopsies by unveiling certain features of the image that help differentiate malignant tumours, allowing for earlier escalation of care..
这家医疗技术巨头已经在ABUS中引入了人工智能(AI),以实现成像过程和癌症检测的自动化。该技术还可以通过揭示图像的某些特征来帮助区分恶性肿瘤,从而减少不必要的活检,实现更早的治疗升级。
Vigneux adds: “Early detection remains the cornerstone of improving breast cancer outcomes, and for women with dense breast tissue, automated whole-breast ultrasound offers a promising advancement. This technology enhances the ability to identify tumours that might otherwise be missed, leading to earlier intervention and better treatment options.”.
维格诺补充说:“早期检测仍然是改善乳腺癌预后的关键,对于乳腺组织致密的女性,自动化的全乳超声提供了一个有前景的进步。这项技术增强了识别可能被遗漏的肿瘤的能力,从而实现更早的干预和更好的治疗选择。”
Vigneux does highlight limitations of the tech. Compared to handheld devices, for example, automated whole-breast ultrasound techniques may employ lower frequency transducers, potentially resulting in lower spatial and contrast resolution compared to hand-held devices.
Vigneux确实指出了该技术的局限性。例如,与手持设备相比,自动全乳腺超声技术可能采用较低频率的换能器,可能导致空间分辨率和对比度分辨率低于手持设备。
The expansion of GE HealthCare’s ultrasound tech will consolidate its market dominance. According to analysis by GlobalData, the company occupies the joint-largest share of the global ultrasound market with Siemens Healthineers. The market is forecast to reach nearly $12bn by 2034, driven by demand for minimally invasive diagnosis in populations with rising average ages..
GE HealthCare的超声技术扩展将巩固其市场主导地位。根据GlobalData的分析,该公司与西门子医疗并列占据全球超声市场最大份额。受人口平均年龄增长对微创诊断需求的推动,预计该市场到2034年将达到近120亿美元。
GE HealthCare is doubling down in the autonomous diagnostics field, announcing
GE HealthCare正在自主诊断领域加大投入,宣布
a partnership with tech giant NVIDIA
与科技巨头英伟达的合作伙伴关系
earlier in March. The two companies will work together on developing AI-enabled X-ray and ultrasound technology.
3月早些时候,两家公司将就开发人工智能驱动的X射线和超声波技术展开合作。
Sign up for our daily news round-up!
注册获取我们的每日新闻汇总!
Give your business an edge with our leading industry insights.
通过我们领先的行业洞察,为您的业务提供优势。
Sign up
注册
Share
分享
Copy Link
复制链接
Share on X
分享到X
Share on Linkedin
分享到领英
Share on Facebook
分享到 Facebook